Cargando…

Pretransplantation seroreactivity in kidney donors and recipients as a predictive factor for posttransplant BKPyV-DNAemia

BK polyomavirus (BKPyV) often reactivates after kidney transplantation, causing BKPyV-associated nephropathy (BKPyVAN) in 1%–10% of cases with a potential detrimental effect on allograft survival. Kidney transplant recipients are regularly screened for BKPyV DNA in plasma. As this strategy may not a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saláková, Martina, Ludvíková, Viera, Hamšíková, Eva, Kolářová, Marie, Šroller, Vojtěch, Viklický, Ondřej, Wohlfahrtová, Mariana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364833/ https://www.ncbi.nlm.nih.gov/pubmed/35967393 http://dx.doi.org/10.3389/fimmu.2022.929946

Ejemplares similares

Biology of the BKPyV: An Update
por: Helle, Francois, et al.
Publicado: (2017)

Genotypes and Variants of BKPyV in Organ Donors after Brain Death
por: Furmaga, Jacek, et al.
Publicado: (2022)

Clinically Relevant Reactivation of Polyomavirus BK (BKPyV) in HLA-A02-Positive Renal Transplant Recipients Is Associated with Impaired Effector-Memory Differentiation of BKPyV-Specific CD8(+) T Cells
por: van Aalderen, Michiel C., et al.
Publicado: (2016)

1189. Correlation of BK polyomavirus (BKPyV)-specific Immunity and BKPyV Viruria within 6 months after Kidney Transplantation: A Prospective Cohort Study
por: Siripoon, Tanaya, et al.
Publicado: (2020)

Longitudinal monitoring of BKPyV miRNA levels in kidney transplant recipients with BKPyV‐related pathology reflects viral DNA levels and remain high in viremia patients after clearance of viral DNA
por: van Doesum, Willem B., et al.
Publicado: (2022)

Discriminating between JCPyV and BKPyV in Urinary Virome Data Sets
por: Mormando, Rita, et al.
Publicado: (2021)

Specific and quantitative detection of Human polyomaviruses BKPyV and JCPyV in the healthy Pakistani population
por: Hussain, Iqra, et al.
Publicado: (2017)

Indoleamine 2,3-Dioxygenase Is Involved in Interferon Gamma’s Anti-BKPyV Activity in Renal Cells
por: Fiore, Tony, et al.
Publicado: (2020)

The role of the DE and EF loop of BKPyV VP1 in the serological cross-reactivity between subtypes
por: Hejtmánková, Alžběta, et al.
Publicado: (2022)

The differential presence of human polyomaviruses, JCPyV and BKPyV, in prostate cancer and benign prostate hypertrophy tissues
por: Shen, Chenghuang, et al.
Publicado: (2021)

Neurological Disease-Affected Patients, including Multiple Sclerosis, Are Poor Responders to BKPyV, a Human Polyomavirus
por: Bononi, Ilaria, et al.
Publicado: (2022)

Human polyomavirus BKPyV and JCPyV serostatus has no impact on women´s human papillomavirus infection outcome
por: Laine, Hanna K., et al.
Publicado: (2023)

Pretransplant BK Virus-Specific T-Cell-Mediated Immunity and Serotype Specific Antibodies May Have Utility in Identifying Patients at Risk of BK Virus-Associated Haemorrhagic Cystitis after Allogeneic HSCT
por: Šťastná-Marková, Markéta, et al.
Publicado: (2021)

Higher Pretransplantation Hemoglobin A1c Is Associated With Greater Risk of Posttransplant Diabetes Mellitus
por: Shin, Jung-Im, et al.
Publicado: (2017)

Specific Detection of Serum Antibodies against BKPyV, A Small DNA Tumour Virus, in Patients Affected by Choroidal Nevi
por: Pietrobon, Silvia, et al.
Publicado: (2017)

Overall of kidney transplant recipients with a pretransplantation cancer history
por: Chargui, Soumaya, et al.
Publicado: (2021)

Induction of APOBEC3-mediated genomic damage in urothelium implicates BK polyomavirus (BKPyV) as a hit-and-run driver for bladder cancer
por: Baker, Simon C., et al.
Publicado: (2022)

Coinfection with Epstein–Barr Virus (EBV), Human Papilloma Virus (HPV) and Polyoma BK Virus (BKPyV) in Laryngeal, Oropharyngeal and Oral Cavity Cancer
por: Drop, Bartłomiej, et al.
Publicado: (2017)

Cross-sectional study on the prevalence of HPV antibodies in the general population of the Czech Republic
por: Hamsikova, Eva, et al.
Publicado: (2013)

Prevalence and viral loads of polyomaviruses BKPyV, JCPyV, MCPyV, TSPyV and NJPyV and hepatitis viruses HBV, HCV and HEV in HIV-infected patients in China
por: Zhou, Xianfeng, et al.
Publicado: (2020)

Genomic Markers Associated with Cytomegalovirus DNAemia in Kidney Transplant Recipients
por: Shapira, Guy, et al.
Publicado: (2023)

Detection Analysis and Study of Genomic Region Variability of JCPyV, BKPyV, MCPyV, HPyV6, HPyV7 and QPyV in the Urine and Plasma of HIV-1-Infected Patients
por: Passerini, Sara, et al.
Publicado: (2022)

Pretransplantation fetal-maternal microchimerism in pediatric liver transplantation from mother
por: Yi, Nam-Joon, et al.
Publicado: (2017)

Risk Factor Analysis for Long-Term Graft Survival Following Pediatric Kidney Transplantation: The Importance of Pretransplantation Time on Dialysis and Donor/Recipient Age Difference
por: Marcou, Marios, et al.
Publicado: (2023)

Acute and Chronic Changes in Gene Expression After CMV DNAemia in Kidney Transplant Recipients
por: Ahn, Richard, et al.
Publicado: (2021)

The risk of early and late cytomegalovirus DNAemia associated with Campath use in stem cell transplant recipients
por: Buyck, Hubertus C, et al.
Publicado: (2009)

934. Epidemiology and Outcomes of Epstein-Barr Virus DNAemia in Adult Solid Organ Transplant Recipients
por: Dong, Sara W, et al.
Publicado: (2021)

Post-transplant lymphoproliferative disorders and Epstein-Barr virus DNAemia in a cohort of lung transplant recipients
por: Baldanti, Fausto, et al.
Publicado: (2011)

2104. Cytomegalovirus DNAemia Patterns in Mismatched Solid Organ Transplant Recipients: A Retrospective Cohort Study.
por: Garcia, Oscar A Fernandez, et al.
Publicado: (2022)

Epstein-Barr Virus DNAemia and post-transplant lymphoproliferative disorder in pediatric solid organ transplant recipients
por: Chang, Yeh-Chung, et al.
Publicado: (2022)

Human Herpesvirus 8 in Australia: DNAemia and Cumulative Exposure in Blood Donors
por: Speicher, David J., et al.
Publicado: (2022)

Pretransplantation use of the second-generation tyrosine kinase inhibitors has no negative impact on the HCT outcome
por: Piekarska, Agnieszka, et al.
Publicado: (2015)

Analysis of Factors Affecting Employment Status of Kidney Transplant Recipients in Selected European Union Member States
por: Wlodarczyk, Elzbieta, et al.
Publicado: (2021)

Plasma proteome perturbation for CMV DNAemia in kidney transplantation
por: Sigdel, Tara K., et al.
Publicado: (2023)

Pretransplant characteristics of kidney transplant recipients that predict posttransplant outcome
por: Tepel, Martin, et al.
Publicado: (2022)

Early referring saved lives in kidney transplant recipients with COVID-19: a beneficial role of telemedicine
por: Zahradka, Ivan, et al.
Publicado: (2023)

Early isolated V-lesion may not truly represent rejection of the kidney allograft
por: Wohlfahrtova, Mariana, et al.
Publicado: (2018)

Association between Antiviral Prophylaxis and Cytomegalovirus and Epstein–Barr Virus DNAemia in Pediatric Recipients of Allogeneic Hematopoietic Stem Cell Transplant
por: Diop, Ndeye Soukeyna, et al.
Publicado: (2021)

2122. The Impact of HHV-6 DNAemia on hematopoietic cell transplant (HCT) recipients at high risk for CMV reactivation in the era of Letermovir
por: Srinivasan, Krithia, et al.
Publicado: (2022)

Bacterial DNAemia is associated with serum zonulin levels in older subjects
por: Gargari, Giorgio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_npru340c50pmcj6bcf9t415bur